» Articles » PMID: 18215972

CT/MRI in Staging Renal Cell Carcinoma

Overview
Journal Cancer Imaging
Publisher Springer Nature
Specialties Oncology
Radiology
Date 2008 Jan 25
PMID 18215972
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Renal cell carcinoma (RCC) is the eighth most common malignancy. It accounts for approximately 3% of newly diagnosed cancers and has been reported to occur in 11 out of 100 000 individuals. The incidence of RCC has increased by 40% in the USA from 1974 to 1990. There appears to be a true increase in the incidence of RCC over and above that attributable to the increased number detected by abdominal cross-sectional imaging. This increase has been accompanied by improved 5-year survival as the tumors detected by imaging are diagnosed at an earlier stage when they are still resectable. The male to female ratio is approximately 2:1; the majority present in the fifth to seventh decade of life and the racial distribution is equal. The majority of cases occur sporadically, but predisposing factors can sometimes be identified. RCC occurs in about 36% of patients with von Hippel-Lindau disease and invasive RCC is three to six times more common among long-term dialysis patients than in the general population.

Citing Articles

Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach.

Jiwani R, Pal K, Paolucci I, Odisio B, Brock K, Tannir N Oncologist. 2025; 30(2).

PMID: 39963829 PMC: 11833245. DOI: 10.1093/oncolo/oyae337.


The Current State of the Diagnoses and Treatments for Clear Cell Renal Cell Carcinoma.

Quinn A, Bell S, Marrah A, Wakefield M, Fang Y Cancers (Basel). 2024; 16(23).

PMID: 39682220 PMC: 11640273. DOI: 10.3390/cancers16234034.


Robotic Partial Radical Nephrectomy for Clinical T3a Tumors: A Narrative Review.

Stout T, Gellhaus P, Tracy C, Steinberg R J Endourol. 2023; 37(9):978-985.

PMID: 37358403 PMC: 10623454. DOI: 10.1089/end.2023.0173.


Sarcomatoid renal cell carcinoma: MRI features and their association with survival.

Cheng M, Duzgol C, Kim T, Ghafoor S, Becker A, Andrieu P Cancer Imaging. 2023; 23(1):16.

PMID: 36793052 PMC: 9930281. DOI: 10.1186/s40644-023-00535-0.


Renal cell carcinoma T staging: Diagnostic accuracy of preoperative contrast-enhanced computed tomography.

Fateh S, Arkawazi L, Tahir S, Rashid R, Rahman D, Aghaways I Mol Clin Oncol. 2023; 18(2):11.

PMID: 36761384 PMC: 9892965. DOI: 10.3892/mco.2023.2607.


References
1.
Hofer C, Kubler H, Hartung R, Breul J, Avril N . Diagnosis and monitoring of urological tumors using positron emission tomography. Eur Urol. 2001; 40(5):481-7. DOI: 10.1159/000049823. View

2.
Ljungberg B, Alamdari F, Rasmuson T, Roos G . Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int. 1999; 84(4):405-11. DOI: 10.1046/j.1464-410x.1999.00202.x. View

3.
Bromwich E, Aitchison M . How should patients be followed up after radical nephrectomy for renal cell cancer?. BJU Int. 2002; 89(1):1-4. DOI: 10.1046/j.1464-4096.2001.01777.x. View

4.
Laissy J, Menegazzo D, Debray M, Toublanc M, Ravery V, Dumont E . Renal carcinoma: diagnosis of venous invasion with Gd-enhanced MR venography. Eur Radiol. 2000; 10(7):1138-43. DOI: 10.1007/s003309900296. View

5.
Goldberg M, Mayo-Smith W, PAPANICOLAOU N, Fischman A, Lee M . FDG PET characterization of renal masses: preliminary experience. Clin Radiol. 1997; 52(7):510-5. DOI: 10.1016/s0009-9260(97)80327-3. View